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Rett syndrome (RTT) is a rare neurodevelopmental disorder,
linked toMECP2 gene mutations in the majority of cases, which
results in severe disability and is associated with several comor-
bidities. The clinical condition of RTT patients tends to stabilize
over time, and prolonged survival has recently been demon-
strated. However, limited information is available on the long-
termcourseofolderpatientswithRTT, especially among those in
Southern Europe. The aim of our study is to evaluate the main
clinical features and state of health of adult Italian patients with
RTT and to present their evolution over time, identifying major
clinical issues present at different ages. A total of 130 families of
patients with RTT aged 14 years were asked to complete a
questionnaire, 84 of which were returned (65%). Among the
clinical characteristics of RTT, stereotypies and poor hand
function and feeding ability remained stable over time, while
nonverbal communication tended to improve. With regard to
the main pathologies, sleep, behavioral, and autonomic disor-
ders persisted into adulthood, while epilepsy improved and
musculoskeletal problems worsened. In our sample, older
patients with R294X and R133C mutations and with C-terminal
deletions showed lower levels of clinical severity. The develop-
ment of guidelines for the clinical management of patients with
RTTwill assist health care providers in dealing with the complex
RTTphenotype.More extensive data about the long-term course
of the condition could help in the design of programs for
secondary prevention of disabilities for younger females affected
by the syndrome.  2011 Wiley Periodicals, Inc.
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INTRODUCTION
Recent years havewitnessed improvements in health care for people
with intellectual disabilities as their life expectancy has increased,
but experience with adult patients with genetic syndromes is still
limited; thus, their needs are not always addressed. Moreover,
patients with intellectual disabilities often have multiple medical
issues. For these reasons, recognition of the clinical and behavioral
characteristics of speciﬁc syndromes and their age-dependent
course is needed to meet the needs of adult patients.
Rett syndrome (RTT) is a neurodevelopmental disorder
almost exclusively affecting females, with an incidence ranging
from 1/10,000 to 1/15,000. More than 70% of cases have mutations
in MECP2 (Methyl CpG Binding protein2), a transcriptional
repressor gene located in Xq28 [Colvin et al., 2003].
Recently, other genes have been identiﬁed as responsible for the
early [Archer et al., 2006; Bahi-Buisson et al., 2008; Artuso et al.,
2010] and the congenital [Mencarelli et al., 2010] variant of the
syndrome.
Clinical presentation of classical RTT usually occurs in the ﬁrst
years of life with regression of early acquired developmental skills,
such as speech and motor functions, and, in particular, loss of
purposeful handuse. The periodof regression is usually followedby
a ‘‘wake-up’’ period associated with some communicative restitu-
tion andpreserved ambulant ability. This stage can last for a variable
period and may be followed by late motor deterioration, mainly
involving gross motor functions [Hagberg, 2002].
It is now well known that the clinical condition of RTT patients
tends to stabilize over time, and their potential for prolonged
survival has recently been demonstrated [Freilinger et al., 2010;
Kirby et al., 2010]. However, the long term-course of older patients
with RTT has not been well studied, especially among patients in
Southern Europe.
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The aim of our study is to evaluate the main clinical features
and state of health of adult Italian patients with RTT and to present
their evolution over time, identifying major clinical issues that
arise at different ages.
METHODS
Study Design
A questionnaire designed to identify the clinical features and main
pathologies among adult RTT patients was sent to all members of
the Italian Association for Rett Syndrome (AIR) who have children
aged14 years. A list of items describing demographic, social, and
clinical assessment was developed based on current literature and
clinicians’ experience with RTT female patients. The patients were
divided into three age groups: 14–20 years (group 1), 21–29 years
(group 2), and over 29 years (group 3). A modiﬁed Kerr score
was used to assess the severity of the disease for each patient [Kerr
et al., 2001]: clinical features including musculoskeletal problems,
gross motor function, hand stereotypies, voluntary hand use,
oromotor difﬁculties, speech, epilepsy, breathing rhythm, periph-
eral circulation, mood disturbances, sleep disturbances, gastro-
intestinal problems, and sitting positions were evaluated, and
different degrees of severity were assigned to each patient, between
0 to 1 and 0 to 3, according to severity. A higher severity score
corresponded to a worse state of health.
Other than theKerr score, parameters related to growthwere not
taken into consideration.
Sample
One-hundred thirty families of AIR were asked to complete an
anonymous questionnaire.
Of these, 84 questionnaires were returned (65%). Most of the
questionnaires were ﬁlled in by the parents of the patients.
Demographic and Social Variables
The ﬁrst part of the questionnaire included questions regarding
demographic and social variables: we asked the families howold the
RTTpatientswere at the timeof the study, if they lived at homeor in
a facility, if they attended a day care center, if they followed any
rehabilitationprogramandwhat kindof school theywere attending
or had attended. Information on the genetic diagnosis was also
requested, if available.
Clinical Variables
Questions concerning clinical characteristics andmain pathologies
were asked in the second part of the questionnaire.
Regarding clinical characteristics, we investigated stereotypies,
grossmotor functions, communication skills, and feeding. For each
item, the parents were asked whether their daughter’s functions
were normal or impaired, or if functions were lost or never
acquired; they were also asked to judge whether the problem
had remained stable, improved or worsened after 14 years of age.
Regarding the main pathologies, we investigated epilepsy, sleep
disorders, behavioral problems, autonomic disorders, gastrointes-
tinal disorders, and musculoskeletal problems. The parents were
asked whether each problemwas absent, mild, moderate, or severe.
Parents were also asked to judge the course of the problems after
14 years of age, selecting among three choices: stable, improved,
or worsened.
Finally, questions were asked about hospitalization and emer-
gency room admission in adolescence and adult age, with a focus
on the main reason for taking the patient to the hospital.
Statistical Analysis
Data were transferred into an electronic database and processed by
Statistical Package for the Social Sciences for Windows (SPSS 18).
Signiﬁcance was set at a P-value of 0.05. Prevalence rates were
calculated for clinical characteristics and continuous variables
were presented as means and standard deviations (SD). Clinical
characteristics of the three age groups were analyzed using Chi
square Tests. Severity score differences between the three groups
and mutation types were assessed with the ANOVA.
RESULTS
Demographic and Social Variables
Mean age at time of the study was 24 years (range 14–42 years, SD
6.7). Mutation analysis had been performed on 76 (90%): 16
patients did not show any mutation (21%); of the remaining cases,
59 MECP2 mutations were identiﬁed (78%) (Table I) and one
patient had a CDKL5 mutation (1%).
Most of the patients lived at home (n¼ 81, 96%), and three lived
in residential facilities (4%). Fifty patients (60%) attended a day
care center.
Compulsory school was completed by most of the patients
(n¼ 60, 71%). Seventy-twopatients participated in a rehabilitation
program (86%), consisting of physical therapy (n¼ 48, 57%),
hydrotherapy (n¼ 47, 56%), horseback riding (n¼ 19, 23%),
TABLE I. Types and Frequencies of MECP2 Mutations Among
Persons With Rett Syndrome
MECP2 mutation type N
% (of 59 with
MECP2 mutation)
R270X, R255X, 750insC 13 22
C-terminal 8 13.6
R294X 6 10.2
R168X, Y141X 5 8.4
R306C 5 8.4
T158M 4 6.8
Del exons 3 and 4 3 5.1
R133C 3 5.1
P152R 2 3.5
P322A 1 1.7
R106W 1 1.7
P225R 1 1.7
T158A 1 1.7
A2V 1 1.7
Unknown or not speciﬁed 5 8.4
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and music therapy (n¼ 20, 24%). Augmentative communication
was utilized by 44 patients (52%).
Clinical Variables
Stereotypies. Hand stereotypies were present in 81 patients
(98%). The stereotyped movements usually involved both hands
andweremost frequently described asmouthing (n¼ 28, 35%) and
hand washing (n¼ 27, 33%).
Use of the hands was never acquired in nine patients (11%), lost
in 33 (39%), and impaired in 37 (44%). Function was preserved in
ﬁve patients (6%).
Grossmotor function. Independent walkingwas possible for 17
RTT patients (20%), while 67 patients (80%) showed varying
degrees of problems with ambulation: 19 (23%) never acquired
this function, 13 (16%) were able to walk but lost this ability (mean
age of loss 11.3 years, range 3–28), and the remaining 35 (41%) of
the patients were able to walk with assistance.
Sitting was considered normal in 31 women (37%), while in 53
patients (63%) this ability was impaired (5 patients [6%] never
acquired this function).
Communication. Communication abilities were classiﬁed as
verbal and nonverbal. Preserved speech was present in only three
patients (4%), while 10 women (12%) spoke a few words. In the
majority of RTT patients (n¼ 42, 50%), language was acquired
and subsequently lost (mean age at loss 2.8 years, range 14 months
to 9 years). The remaining 29 women (35%) never acquired
the ability to speak. However, nonverbal communication was
reported in 64 patients (76%), mainly through eye contact.
Among thosewhose nonverbal communicationwas compromised,
12 patients (60%) demonstrated improvement over time.
Feeding. Feeding was considered normal in more than half of
the sample (n¼ 45, 54%); among these patients, 62 (75%)were able
to chew and 26 (31%) could bring food to the mouth themselves.
Three patients required percutaneous endoscopic gastrostomy
(PEG) placement.
The course of the clinical characteristics is described in Figure 1.
Main Pathologies
Epilepsy. A seizure disorder was reported in 69 patients (82%),
with amean age at onset of 5 years (range 1–16 years). Seizureswere
controlled by medications in 28 patients (41%), while in ﬁve
patients (7%) antiepileptic therapy was withdrawn without recur-
rence. Eleven patients (16%) presented only sporadic seizures.
Epilepsy was drug-resistant in 25 patients (36%), with the need
for an antiepileptic polytherapy in most cases (60%). Twenty-ﬁve
patients with epilepsy (36%) experienced status epilepticus at least
once in their life.
Sleepdisorders. Sleepdisorderswere reported in themajority of
patients (n¼ 65, 77%), even if considered a mild problem by the
parents. The most frequent disorder was night waking (n¼ 47,
56%), followed by precocious morning waking (n¼ 29, 35%) and
resistance to falling asleep (n¼ 19, 23%). To limit or avoid sleep
disorders, 31 patients (48%) were on therapy with melatonin or
niaprazine.
Behavioral problems. Behavioral disorders were present in 58
patients (69%), mainly agitation (n¼ 39, 46%) and depressed
mood (n¼ 36, 43%).
Autonomic disorders. Breathing anomalies were present in 59
patients (70%), mainly apnea (n¼ 48, 57%) and hyperventilation
(n¼ 30, 36%).Heart arrhythmias, documented by ECGanomalies,
were reported in 15 women (18%).
A majority of patients suffered from vasculocutaneous disorders
(n¼ 77, 92%): cold feet were described in 73 patients (87%),
cyanotic extremities in 30 (36%), atrophic skin and nail modiﬁ-
cations in 17 (20%).
Gastrointestinal disorders. Gastrointestinal disturbances have
a high prevalence in our sample (n¼ 75, 89%), and required
therapies in 54% (n¼ 45). Constipation was the most frequent
disorder (n¼ 71, 85%).Gastroesophageal reﬂuxwas reported in 21
(25%) of the patients and tended to improve over time (P¼ 0.003).
Musculoskeletal problems. Musculoskeletal problems were
often experienced (n¼ 81, 96%), scoliosis being the most frequent
problem reported (n¼ 70, 83%). Reported disorders also included
spasticity (n¼ 43, 51%) and joint deformities (n¼ 30, 36%), the
latter signiﬁcantly worsening with increasing age (P¼ 0.028).
Osteoporosis was reported in 38 women (45%) and was docu-
mented by dual energy X-ray absorptiometry scanning in all of
these.
The course of the main disorders is described in Figure 2.
Age Groups and Severity Score
We found a statistically signiﬁcant difference in severity scores
among the three groups (P< 0.05). Speciﬁcally, a signiﬁcant differ-
ence was noted between group 1 (14–20 years, mean severity score
17.73) andgroup3(>29 years,mean severity score 14.95), theolder
group having a less severe score, with a P-value of 0.018, and
between group 2 (21–29 years, mean severity score 18.77) and
group 3, the older group having a less severe score, with a P-value
of 0.002.
FIG. 1. Course of the clinical characteristics among persons with
Rett syndrome after 14 years of age.
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Mutation Type and Severity Score
No statistically signiﬁcant difference between mutation type and
severity score was found. However, we were able to describe
different scores for different mutations: the lower score
(corresponding to a less impaired state of health) was found in
patients with C-terminal deletions (score¼ 15.88) and with R294X
(score¼ 15.17) and R133C (score¼ 12.33) mutations, while a
higher score was found in patients with large deletions of exons
3 and 4 (score¼ 19.00), in patients with R270X, R255X, 750insC
(score¼ 18.54), and in those without a molecular diagnosis
(score¼ 18.63).
Hospitalization
Most patients (n¼ 55, 66%) had been admitted to the hospital for
clinical and instrumental follow-up or for emergency reasons at
least once. Emergency room care was reported for 31 patients
(37%): the main reasons were trauma and/or bone fractures
(n¼ 12, 39%) and seizures (n¼ 9, 29%).
DISCUSSION
As survival improves, clinicians are increasingly faced with caring
for adults with genetic syndromes. Clinical management of their
medical problems is often challenging. The long-term course of
RTT has been described in different groups of patients fromNorth
America [Kirby et al., 2010], Australia [Moore et al., 2005], Sweden
[Hagberg, 2005], the United Kingdom [Cass et al., 2003] and the
Netherlands [Halbach et al., 2008; Smeets et al., 2009], but the
description of adult patients with RTT from Southern Europe has
been lacking. Our study provides information on these patients,
including clinical and behavioral problems identiﬁed among
patients of RTT at different ages. These ﬁndings could be used
to design speciﬁc intervention programs for adults with RTT.
Our response rate was relatively high (65%), suggesting that the
respondents were highly motivated to provide information about
RTT to researchers. However, our study has inherent limitations.
Speciﬁcally, data were obtained from the patients’ parents in most
cases, and parentsmaymisreport some clinical details. It is possible
that those who completed the survey may be different from those
who refused (e.g., they may put more effort into their daughters’
care, and thus, their health might be better: this could result in a
potential bias).
Based on our results and those of the recent literature [Vignoli
et al., 2009; Carter et al., 2010], it appears that stereotypies tend
to persist over time. Hand function may be able to be maintained,
even though impaired, in half of our patients. This skill should
be developed as much as possible, since patients may be able to
perform some functions themselves (e.g., a third of our sample are
able to bring food to their mouths on their own).
On the other hand, gross motor skills tend to worsen over
time [Downs et al., 2008a]; independent ambulation or at least
ambulation with support should be encouraged as long as
possible. The maintenance of this ability is important both for
the care of the patients as well as for maintaining their personal
interests and providing appropriate stimuli.
Relevant consideration should be addressed to communication
abilities in RTT. Although expressive language is often lost in the
early stage of the disease, comprehension skills can be maintained.
Moreover, nonverbal abilities can be developed and can also
improve over time, as previously described and shown in our study
[Fontanesi and Haas, 1988; Halbach et al., 2008; Fabio et al., 2009].
Considering the main diseases involving adult RTT patients,
epilepsy still represents amajor concern, since a seizure disorder has
been experienced by 81% of the patients. This high percentage is
consistent with previous studies [Jian et al., 2007; Halbach et al.,
2008; Smeets et al., 2009; Pintaudi et al., 2010], although it may be
that seizures are over reported [Glaze et al., 2010].
Our data conﬁrms that more than third of females with RTT
have drug-resistant epilepsy, which usually requires antiepileptic
drug polytherapy and can be complicated by status epilepticus.
In addition, the possibility of withdrawing antiepileptic therapy in
selected patients should be considered, as also suggested by other
authors [Lotan et al., 2010].
Families of RTT patients have to deal with sleep and behavioral
problems; melatonin seems to be effective in regulating the sleep
cycle in these patients [McArthur and Budden, 1998; Miyamoto
et al., 1999] and is widely used in our sample. Behavioral disorders
are more difﬁcult to control and studies in this ﬁeld are lacking.
Regarding autonomic disturbances, our data conﬁrm that these
are still present in adulthood, as previously described [Cass et al.,
2003; Halbach et al., 2008].
One of the most striking issues in adult patients was scoliosis:
guidelines for management of this speciﬁc problem have recently
been developed [Downs et al., 2009]. Intensive physical therapy
and other preventive measures should be provided for scoliosis,
as reported by Lotan et al. [2005], but also for joint deformities,
which tend to worsen over time.
Moreover, patients with RTT show a high risk of fractures
due to early onset osteoporosis, as previously stated for the
Australian population. Intervention to prevent fractures should
be considered [Downs et al., 2008b; Motil et al., 2008].
In comparison to other groups of RTT patients where 20%,
mainly in the older age group, had enteral nutrition support [Oddy
et al., 2007], feeding ability was considered adequate in more than
half of our patients, withonly three patients needing thepositioning
FIG. 2. Course of health issues among persons with Rett syndrome
after 14 years of age.
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of a PEG. Nevertheless, gastrointestinal problems are major issues
in the RTT population, with constipation and gastroesophageal
reﬂux being the most frequently reported. Medical therapy should
be addressed to prevent worsening of these issues, and feeding
programs should be developed to avoid malnutrition and its
consequences [Oddy et al., 2007; Motil et al., 2009; Prior et al.,
2010].
Patients in the oldest age group (>29 years) had statistically
signiﬁcant less severe scores than the patients in the two younger
groups: this could be explained by the fact that the patients with
more severe conditions died before reaching their thirties, and
only patients with a milder phenotype survived. These ﬁndings are
consistent with current literature [Colvin et al., 2004; Bebbington
et al., 2010] and corroborate the evidence that older patients with
RTT have a milder phenotype.
Although it was difﬁcult to assess statistically signiﬁcant differ-
ences between individual mutations due to power limitations,
patients with C-terminal deletions and R294X and R133C muta-
tions had lower severity scores, while patients carrying large dele-
tions and patients without mutations were more severely affected.
Our ﬁnding that patients without mutations have a more severe
phenotype is consistent with a previous study by Temudo et al.
[2011]. It is also possible that the patients without mutations
underwent molecular testing beforeMultiplex Ligation-dependent
Probe Ampliﬁcation was introduced in routine analysis. These
patientsmay have large deletions that weremissed on earlier testing
[Scala et al., 2007], explaining our ﬁndings of amore impaired state
of health in them.
We believe that the complex phenotype of RTT requires more
extensive medical care and that guidelines for clinical management
of adolescent and adult patients with RTT are needed. Our study
provides insight into the main problems of RTT in adulthood and
may be helpful in addressing appropriate therapies.However, given
our study’s limitations, we encourage further longitudinal studies
to collect more extensive data about the long-term course of the
syndrome, which may be helpful in the design of intervention
programs for younger patients with RTT.
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